Cargando…

SPIB is a novel prognostic factor in diffuse large B‐cell lymphoma that mediates apoptosis via the PI3K‐AKT pathway

Although the clinical outcomes of diffuse large B‐cell lymphoma (DLBCL) have improved in the immunochemotherapy era, approximately one‐third of patients develop intractable disease. To improve clinical outcomes for these patients, it is important to identify those with poor prognosis prior to initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Yusuke, Shimada, Kazuyuki, Shimada, Satoko, Sakamoto, Akihiko, Naoe, Tomoki, Nakamura, Shigeo, Hayakawa, Fumihiko, Tomita, Akihiro, Kiyoi, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021043/ https://www.ncbi.nlm.nih.gov/pubmed/27348272 http://dx.doi.org/10.1111/cas.13001

Ejemplares similares

Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells
por: Sugimoto, Keiki, et al.
Publicado: (2015)

Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells
por: Sakamoto, Akihiko, et al.
Publicado: (2018)

Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
por: Aoki, Tomohiro, et al.
Publicado: (2016)

De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: Molecular mechanisms and correlation with rituximab sensitivity
por: Tokunaga, Takashi, et al.
Publicado: (2014)

Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
por: Kunou, Shunsuke, et al.
Publicado: (2021)

Current progress and future perspectives of research on intravascular large B‐cell lymphoma
por: Shimada, Kazuyuki, et al.
Publicado: (2021)

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome
por: Xu, Jinglan, et al.
Publicado: (2008)

spib is required for primitive myeloid development in Xenopus
por: Costa, Ricardo M. B., et al.
Publicado: (2008)

Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
por: Fukushima, Nobuaki, et al.
Publicado: (2016)

Peripheral blood cell‐free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes
por: Suzuki, Yasuhiro, et al.
Publicado: (2016)

The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
por: Morishita, Takanobu, et al.
Publicado: (2016)

Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography
por: Sakashita, Gyosuke, et al.
Publicado: (2018)

Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB
por: Ding, Meng, et al.
Publicado: (2022)

SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity
por: Care, Matthew A., et al.
Publicado: (2014)

Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
por: Chen, Fangli, et al.
Publicado: (2016)

Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol
por: Goto, Tatsunori, et al.
Publicado: (2018)

Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB
por: Willis, Simon N., et al.
Publicado: (2017)

SpiB regulates the expression of B-cell-related genes and increases the longevity of memory B cells
por: Horiuchi, Shu, et al.
Publicado: (2023)

Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression
por: Wang, Jianqun, et al.
Publicado: (2021)

Superficial Parasternal Intercostal Plane Blocks (SPIB) With Buprenorphine, Magnesium, and Bupivacaine for Management of Pain in Coronary Artery Bypass Grafting
por: Krishnan, Sandeep, et al.
Publicado: (2022)

PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
por: Suzuki, Yuka, et al.
Publicado: (2020)

Integrated transcriptomic and regulatory network analyses uncovers the role of let-7b-5p, SPIB, and HLA-DPB1 in sepsis
por: Mohsin, Mohd, et al.
Publicado: (2022)

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
por: Hatta, Yoshihiro, et al.
Publicado: (2018)

Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review
por: Sakakibara, Ayako, et al.
Publicado: (2021)

RHOF PROMOTES MURINE MARGINAL ZONE B CELL DEVELOPMENT
por: KISHIMOTO, MAYUKO, et al.
Publicado: (2014)

Clonal Analysis of Multiple Point Mutations in the N‐ras Gene in Patients with Acute Myeloid Leukemia
por: Kubo, Kazuaki, et al.
Publicado: (1993)

INCREASING AND DECREASING PHASES OF FERRITIN AND HEMOSIDERIN IRON DETERMINED BY SERUM FERRITIN KINETICS
por: SAITO, HIROSHI, et al.
Publicado: (2013)

DETERMINATION OF FERRITIN AND HEMOSIDERIN IRON IN PATIENTS WITH NORMAL IRON STORES AND IRON OVERLOAD BY SERUM FERRITIN KINETICS
por: SAITO, HIROSHI, et al.
Publicado: (2012)

Poles and zeros in pi pi scattering amplitudes
por: Eguchi, T, et al.
Publicado: (1974)

Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
por: Ono, Takaaki, et al.
Publicado: (2014)

Unusual presentation of recurrent follicular lymphoma as diffuse granular shadow
por: Ito, Takayasu, et al.
Publicado: (2021)

Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia
por: Kobayashi, Yukio, et al.
Publicado: (2015)

Chemical Peeling Therapy Using Phenol for the Cervico-Vaginal Intraepithelial Neoplasia
por: Maehama, Toshiyuki, et al.
Publicado: (2023)

Clinicopathological analysis of primary intestinal diffuse large B‐cell lymphoma: Prognostic evaluation of CD5, PD‐L1, and Epstein‐Barr virus on tumor cells
por: Ishikawa, Eri, et al.
Publicado: (2018)

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
por: Freiburghaus, Catja, et al.
Publicado: (2018)

A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era
por: Ishikawa, Eri, et al.
Publicado: (2018)

Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study
por: Kawashima, Naomi, et al.
Publicado: (2020)

1018. Prevalence of Bacteremia/Fungemia and Pneumonia in Remission Induction Chemotherapy for Adult Acute Myeloid Leukemia From 1987 to 2005: Japan Adult Leukemia Study Group (JALSG)
por: Kato, Hideaki, et al.
Publicado: (2018)

Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease
por: Oka, Shomi, et al.
Publicado: (2013)

PI3K/AKT addiction in subsets of diffuse large B-cell lymphoma
por: Pfeifer, Matthias, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n8akmbl9mne9sptd27018gqm4o